Fact sheet: JPM Gbl Healthcare

Fund information

Fund name
JPM Global Healthcare A Acc NAV USD
Fund company manager
JPMorgan Asset Mgmt (Europe) S
Fund type
SIB
Fund manager
Scott Braunstein
since 02/10/2009
Fund objective
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

10.45 %

1 Year rank in sector

11/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.9 b

FE Risk score

142

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    69.2%
  • Europe & Middle East
    23.3%
  • UK
    5.3%
  • Japan
    1.2%
  • Money Market
    1%
  • Biotechnology/Medical
    49.1%
  • Pharmaceuticals
    31.8%
  • Health Care
    18.1%
  • Money Market
    1%
  • North American Equities
    69.2%
  • International Equities
    23.3%
  • UK Equities
    5.3%
  • Japanese Equities
    1.2%
  • Money Market
    1%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund5.56 %9.07 %10.45 %9.29 %98.99 %
Sector3.91 %3.54 %8.23 %20.27 %97.29 %
Rank within sector9 / 308 / 3011 / 2921 / 2711 / 23
Quartile th2 nd2 nd2 nd4 th2 nd

Calendar performance

YTD-20172016201520142013
Fund20.16 %-15.42 %2.14 %22.01 %61.04 %
Sector15.31 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector9 / 2922 / 2922 / 2719 / 244 / 23
Quartile th2 nd4 th4 th4 th1 st

Risk statistics

Alpha-3.06
Beta0.9
Sharpe-0
Volatility14.27
Tracking error4.09
Information ratio-0.91
R-Squared0.93

Price movement

52 week high307.08
52 week low241.05
Current bid price0
Current offer price0
Current mid price301.71

Holdings by region

  • 69.2% North America
  • 23.3% Europe & Middle East
  • 5.3% UK
  • 1.2% Japan
  • 1% Money Market

Holdings by sector

  • 49.1% Biotechnology/Medical
  • 31.8% Pharmaceuticals
  • 18.1% Health Care
  • 1% Money Market

Holdings by asset type

  • 69.2% North American Equities
  • 23.3% International Equities
  • 5.3% UK Equities
  • 1.2% Japanese Equities
  • 1% Money Market

Individual holdings

  • 6.2% UNITEDHEALTH GROUP INC
  • 5.4% ROCHE HLDG AG
  • 4.3% CELGENE CORP
  • 3.5% BAYER AG
  • 3.2% ALLERGAN INC
  • 3% LILLY (ELI) & CO
  • 2.9% SANOFI
  • 2.9% SHIRE PLC
  • 2.8% BRISTOL MYERS SQUIBB SA
  • 2.7% VERTEX PHARMACEUTICAL